Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEE

ClinicalTrials.gov ID: NCT07723976

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07723976. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 21, 2026, 4:54 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Cannabidiol Oral Solution (CBD-OS, JZP926-OS) in Participants Aged 1 Year and Older With Developmental and Epileptic Encephalopathy (DEE)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The efficacy, safety, and tolerability of CBD-OS have been evaluated for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), and Tuberous sclerosis complex (TSC). The current JZP926-303 study is being conducted to evaluate the safety and efficacy of CBD-OS in participants with Developmental and Epileptic Encephalopathy (DEE).

Study identification

NCT ID
NCT07723976
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Jazz Pharmaceuticals
Industry
Enrollment
120 participants

Conditions and interventions

Eligibility (public fields only)

Age range
1 Year and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 30, 2026 (Actual)
Primary completion
Sep 4, 2029 (Estimated)
Completion
Sep 4, 2029 (Estimated)
Last update posted
Nov 17, 2026

2026 – 2029

United States locations

U.S. sites
18
U.S. states
14
U.S. cities
17
Facility City State ZIP Site status
University Of Alabama Birmingham Birmingham Alabama 35233 Not yet recruiting
Barrow Institute (ESC) Phoenix Arizona 85013 Not yet recruiting
UC Irvine Orange California 92868 Not yet recruiting
Sutter Health Sacramento California 95816 Not yet recruiting
UC Davis Health Midtown Ambulatory Care Center Sacramento California 95817 Not yet recruiting
Yale School Of Medicine (ESC) New Haven Connecticut 06504 Not yet recruiting
(DEECRN) Children's National Hospital Friendship Heights; Children's National Medical Center Washington D.C. District of Columbia 20016 Not yet recruiting
Pediatric Epilepsy & Neurology Specialists (PENS) Tampa Florida 33609 Not yet recruiting
Hawaii Pacific Neuroscience (HPN) Comprehensive Epilepsy Center Honolulu Hawaii 96817 Recruiting
Sinai Hospital of Baltimore Baltimore Maryland 21209 Not yet recruiting
Mid Atlantic Epilepsy And Sleep Center (ESC) Bethesda Maryland 20817 Recruiting
Hackensack Meridian Neuroscience Institute At JFK University Medical Center Edison New Jersey 08820 Not yet recruiting
Northwell Health Division Of Pediatric Neurology (ESC) Lake Success New York 11042 Not yet recruiting
(DEECRN) Weill Cornell Medicine Pediatric Neurology New York New York 10021 Not yet recruiting
Cincinnati Children's Hospital Medical Center (ESC) Cincinnati Ohio 45229 Not yet recruiting
(DEECRN) The Children's Hospital Of Philadelphia (CHOP) Philadelphia Pennsylvania 19104 Not yet recruiting
McGovern Medical School UT Physicianspediatric Neurology Texas Medical Center Houston Texas 77030 Not yet recruiting
Seattle Children's Hospital Seattle Washington 98105 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07723976, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 17, 2026 · Synced Nov 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.